Skip to main content

Articles

Page 56 of 70

  1. To determine the efficacy of high dose rate endobronchial brachytherapy (HDR-BT) for the treatment of centrally located lung tumors, two different fractionation schedules were compared regarding local tumor re...

    Authors: Olivier M Niemoeller, Barbara Pöllinger, Maximilian Niyazi, Stefanie Corradini, Farkhad Manapov, Claus Belka and Rudolf M Huber
    Citation: Radiation Oncology 2013 8:8
  2. Whole pelvis intensity modulated radiotherapy (IMRT) is increasingly being used to treat cervical cancer aiming to reduce side effects. Encouraged by this, some groups have proposed the use of simultaneous int...

    Authors: Fernanda G Herrera, Sharon Callaway, Ela Delikgoz-Soykut, Mehtap Coskun, Laetitia Porta, Jean-Yves Meuwly, Joao Soares-Rodrigues, Leonie Heym, Raphael Moeckli and Mahmut Ozsahin
    Citation: Radiation Oncology 2013 8:5
  3. Ongoing prospective trials exploring stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) often exclude minimally invasive adenocarcinoma or adenocarcnioma in situ, former...

    Authors: Shahed N Badiyan, Andrew J Bierhals, Jeffrey R Olsen, Kimberly M Creach, Adam A Garsa, Todd DeWees, Jeffrey D Bradley and Clifford G Robinson
    Citation: Radiation Oncology 2013 8:4
  4. Currently, the inhomogeneity of the pulmonary function is not considered when treatment plans are generated in thoracic cancer radiotherapy. This study evaluates the dose of treatment plans on highly-functiona...

    Authors: Tzung-Chi Huang, Chien-Yi Hsiao, Chun-Ru Chien, Ji-An Liang, Tzu-Ching Shih and Geoffrey G Zhang
    Citation: Radiation Oncology 2013 8:3
  5. To evaluate the efficacy of radiotherapy (RT) for early-stage nodal and extranodal marginal zone lymphoma (MZL).

    Authors: Kristin Deinbeck, Hans Geinitz, Bernhard Haller and Khashayar Fakhrian
    Citation: Radiation Oncology 2013 8:2
  6. To integrate 3D MR spectroscopy imaging (MRSI) in the treatment planning system (TPS) for glioblastoma dose painting to guide simultaneous integrated boost (SIB) in intensity-modulated radiation therapy (IMRT).

    Authors: Soléakhéna Ken, Laure Vieillevigne, Xavier Franceries, Luc Simon, Caroline Supper, Jean-Albert Lotterie, Thomas Filleron, Vincent Lubrano, Isabelle Berry, Emmanuelle Cassol, Martine Delannes, Pierre Celsis, Elizabeth Moyal Cohen-Jonathan and Anne Laprie
    Citation: Radiation Oncology 2013 8:1
  7. For skull base meningiomas, several treatment paradigms are available: Observation with serial imaging, surgical resection, stereotactic radiosurgery, radiation therapy or some combination of both. The choice ...

    Authors: Stephanie E Combs, Ute Ganswindt, Robert L Foote, Douglas Kondziolka and Jörg-Christian Tonn
    Citation: Radiation Oncology 2012 7:226
  8. Skull base meningiomas commonly present with cranial neuropathies. Fractionated stereotactic radiation therapy (FSRT) has been used to treat these tumors with excellent local control, but rates of improvement ...

    Authors: Xinglei Shen, David W Andrews, Robert C Sergott, James J Evans, Walter J Curran, Mitchell Machtay, Ruben Fragoso, Harriet Eldredge, Colin E Champ, Matthew Witek, Mark V Mishra, Adam P Dicker and Maria Werner-Wasik
    Citation: Radiation Oncology 2012 7:225
  9. Hypothyroidism is a frequent late side effect of radiation therapy of the cervical region. Purpose of this work is to develop multivariate normal tissue complication probability (NTCP) models for radiation-ind...

    Authors: Laura Cella, Raffaele Liuzzi, Manuel Conson, Vittoria D’Avino, Marco Salvatore and Roberto Pacelli
    Citation: Radiation Oncology 2012 7:224
  10. As the incidence of cancer continues to rise, the use of radiotherapy has emerged as a leading treatment modality. Preclinical models in radiation oncology are essential tools for cancer research and therapeut...

    Authors: Jenna Kahn, Philip J Tofilon and Kevin Camphausen
    Citation: Radiation Oncology 2012 7:223
  11. The purpose of this study was to investigate whether the excision repair cross-complementation group 1 (ERCC1) mRNA expression could predict treatment response of patients with locally advanced cervical squamo...

    Authors: Zhou-lan Bai, Yan-yang Wang, Hong Zhe, Jian-li He and Ping Hai
    Citation: Radiation Oncology 2012 7:221
  12. Adjuvant radiation therapy (RT) with temozolomide (TMZ) is standard of care for high grade gliomas (HGG) patients. RT is commonly started 3 to 5 weeks after surgery. The deformation of the tumor bed and brain ...

    Authors: Colin E Champ, Joshua Siglin, Mark V Mishra, Xinglei Shen, Maria Werner-Wasik, David W Andrews, Sonal U Mayekar, Haisong Liu and Wenyin Shi
    Citation: Radiation Oncology 2012 7:220
  13. The utility of definitive radiotherapy (RT) for locoregionally advanced squamous cell carcinoma (SCC) of the larynx or hypopharynx in the setting of thyroid or cricoid cartilage invasion (TCCI) is controversia...

    Authors: Marcus M Wagner, Joel K Curé, Jimmy J Caudell, Sharon A Spencer, Lisle M Nabell, William R Carroll and James A Bonner
    Citation: Radiation Oncology 2012 7:219
  14. The use of stereotactic body radiotherapy (SBRT) is rapidly increasing. Presently, the most accurate method uses fiducial markers implanted near the tumor. A shortcoming of this method is that the beams turn o...

    Authors: Rie Yamazaki, Seiko Nishioka, Hiroyuki Date, Hiroki Shirato, Takao Koike and Takeshi Nishioka
    Citation: Radiation Oncology 2012 7:218
  15. Standard 3D-CRT after BCS may cause skin toxicity with a wide range of intensity including acute effects like erythema or late effects. In order to reduce these side effects it is mandatory to identify potenti...

    Authors: Uta Kraus-Tiefenbacher, Andreas Sfintizky, Grit Welzel, Anna Simeonova, Elena Sperk, Kerstin Siebenlist, Sabine Mai and Frederik Wenz
    Citation: Radiation Oncology 2012 7:217
  16. Studies suggest that patients with metastases limited in number and destination organ benefit from metastasis-directed therapy. Stereotactic body radiotherapy (SBRT) is commonly used for metastasis directed th...

    Authors: Abhishek A Solanki, Ralph R Weichselbaum, Daniel Appelbaum, Karl Farrey, Kamil M Yenice, Steven J Chmura and Joseph K Salama
    Citation: Radiation Oncology 2012 7:216
  17. The aim of this study was to compare the outcomes of postoperative adjuvant concomitant chemoradiotherapy using two different schedules of cisplatin for patients with high-risk oral squamous cell carcinoma (OS...

    Authors: Din-Li Tsan, Chien-Yu Lin, Chung-Jan Kang, Shiang-Fu Huang, Kang-Hsing Fan, Chun-Ta Liao, I-How Chen, Li-Yu Lee, Hung-Ming Wang and Joseph Tung Chieh Chang
    Citation: Radiation Oncology 2012 7:215
  18. Autophagy has attracted attentions as a novel mechanism for tumor development. In this study Human ovarian carcinoma cell line SKOV3 and multidrug-resistant phenotype SKVCR cells were used and the roles of aut...

    Authors: Bing Liang, Dejuan Kong, Yang Liu, Nan Liang, Mengzi He, Shumei Ma and Xiaodong Liu
    Citation: Radiation Oncology 2012 7:213
  19. This study investigates the use of TomoDirectTM 3DCRT for whole breast adjuvant radiotherapy (AWBRT) that represents a very attractive treatment opportunity, mainly for radiotherapy departments without convention...

    Authors: Valeria Casanova Borca, Pierfrancesco Franco, Paola Catuzzo, Fernanda Migliaccio, Flora Zenone, Stefania Aimonetto, Andrea Peruzzo, Massimo Pasquino, Giuliana Russo, Maria Rosa La Porta, Domenico Cante, Piera Sciacero, Giuseppe Girelli, Umberto Ricardi and Santi Tofani
    Citation: Radiation Oncology 2012 7:211
  20. The outcome of patients after radiotherapy (RT) for localized prostate cancer in case of prostate-specific antigen (PSA) progression during primary hormonal therapy (HT) is not well known.

    Authors: Michael Pinkawa, Marc D Piroth, Richard Holy, Victoria Djukic, Jens Klotz, David Pfister, Axel Heidenreich and Michael J Eble
    Citation: Radiation Oncology 2012 7:209
  21. To report early outcome and toxicity for inoperable patients with hepatocellular carcinoma (HCC) treated with volumetric modulated arc therapy (VMAT).

    Authors: Po-Ming Wang, Wei-Chung Hsu, Na-Na Chung, Feng-Ling Chang, Antonella Fogliata and Luca Cozzi
    Citation: Radiation Oncology 2012 7:207
  22. There is evidence that the extent of the G2/M arrest following irradiation is correlated with tumour cell survival and hence therapeutic success. We studied the regulation of cellular response to radiation tre...

    Authors: Nataša Anastasov, Ines Höfig, Iria Gonzalez Vasconcellos, Kristina Rappl, Herbert Braselmann, Natalie Ludyga, Gert Auer, Michaela Aubele and Michael J Atkinson
    Citation: Radiation Oncology 2012 7:206
  23. Breast tissue is among the most sensitive tissues to the carcinogenic actions of ionizing radiation and epidemiological studies have linked radiation exposure to breast cancer. Currently, molecular understandi...

    Authors: Kamal Datta, Daniel R Hyduke, Shubhankar Suman, Bo-Hyun Moon, Michael D Johnson and Albert J Fornace Jr
    Citation: Radiation Oncology 2012 7:205
  24. SBRT is a safe and efficient strategy to locally control multiple metastatic sites. While research in the physics domain for Flattening Filter Free Beams (FFF) beams is increasing, there are few clinical data ...

    Authors: Filippo Alongi, Antonella Fogliata, Elena Clerici, Pierina Navarria, Angelo Tozzi, Tiziana Comito, Anna Maria Ascolese, Alessandro Clivio, Francesca Lobefalo, Giacomo Reggiori, Luca Cozzi, Pietro Mancosu, Stefano Tomatis and Marta Scorsetti
    Citation: Radiation Oncology 2012 7:204
  25. The purpose of this study was to evaluate the technical feasibility of an image-guided intensity modulated radiotherapy (IG-IMRT) using involved-field technique to perform a hypofractionated schedule for patie...

    Authors: Seok Hyun Son, Jin Ho Song, Byung Ock Choi, Young nam Kang, Myung Ah Lee, Ki Mun Kang and Hong Seok Jang
    Citation: Radiation Oncology 2012 7:203
  26. An earlier study from our group of long time survivors of head and neck cancer who had received a low radiation dose to the hypothalamic-pituitary region, with no signs of recurrence or pituitary dysfunction, ...

    Authors: Erik Olsson, Carl Eckerström, Gertrud Berg, Magnus Borga, Sven Ekholm, Gudmundur Johannsson, Susanne Ribbelin, Göran Starck, Anna Wysocka, Elisabet Löfdahl and Helge Malmgren
    Citation: Radiation Oncology 2012 7:202
  27. Chemoradiation is the standard treatment for anal cancer. 3D conformal radiotherapy (3D-CRT) is usually split in 2 sequences with a therapeutic break (gap) in between. Intensity-modulated radiation therapy (IM...

    Authors: Claire Vautravers Dewas, Philippe Maingon, Cécile Dalban, Aurélie Petitfils, Karine Peignaux, Gilles Truc, Etienne Martin, Cédric Khoury, Sylvain Dewas and Gilles Créhange
    Citation: Radiation Oncology 2012 7:201
  28. To quantify the incidental irradiation dose to esophageal lymph node stations when irradiating T1-4N0M0 thoracic esophageal squamous cell carcinoma (ESCC) patients with a dose of 60 Gy/30f.

    Authors: Kai Ji, Lujun Zhao, Chengwen Yang, Maobin Meng and Ping Wang
    Citation: Radiation Oncology 2012 7:200
  29. We would like to investigate the if IMRT produced better target coverage and dose sparing to adjacent normal structures as compared with 3-dimensional conformal radiotherapy (3DCRT) and lateral opposing fields...

    Authors: Victor HF Lee, Sherry CY Ng, Cheuk Wai Choi, Mai Yee Luk, To Wai Leung, Gordon KH Au and Dora LW Kwong
    Citation: Radiation Oncology 2012 7:199
  30. Current clinical guidelines for the management of radiotherapy patients having either a pacemaker or implantable cardioverter defibrillator (both CIEDs: Cardiac Implantable Electronic Devices) do not cover mod...

    Authors: Coen W Hurkmans, Joost L Knegjens, Bing S Oei, Ad JJ Maas, GJ Uiterwaal, Arnoud J van der Borden, Marleen MJ Ploegmakers and Lieselot van Erven
    Citation: Radiation Oncology 2012 7:198
  31. To quantitatively evaluate the safety and related-toxicities of intensity modulated radiotherapy (IMRT) dose–volume histograms (DVHs), as compared to the conventional three-dimensional conformal radiotherapy (...

    Authors: Baojuan Yang, Lin Zhu, Haiyan Cheng, Qi Li, Yunyan Zhang and Yashuang Zhao
    Citation: Radiation Oncology 2012 7:197
  32. Low risk prostate cancers are commonly treated with low dose rate (LDR) brachytherapy involving I-125 seeds. The implementation of a ‘live-planning’ technique at the Royal Adelaide Hospital (RAH) in 2007 enabl...

    Authors: Joshua Moorrees, John M Lawson and Loredana G Marcu
    Citation: Radiation Oncology 2012 7:196
  33. Rectal cancer accounts for approximately one third of all colorectal cancers (CRC), which belong among leading causes of cancer deaths worldwide. Standard treatment for locally advanced rectal cancer (cT3/4 an...

    Authors: Marek Svoboda, Jiri Sana, Pavel Fabian, Ilona Kocakova, Jana Gombosova, Jana Nekvindova, Lenka Radova, Rostislav Vyzula and Ondrej Slaby
    Citation: Radiation Oncology 2012 7:195
  34. As the long-term efficacy of stereotactic body radiation therapy (SBRT) becomes established and other prostate cancer treatment approaches are refined and improved, examination of quality of life (QOL) followi...

    Authors: Alan Katz, Montserrat Ferrer and José Francisco Suárez
    Citation: Radiation Oncology 2012 7:194
  35. There is broad consensus on surgical resection being the backbone of curative therapy of gastric- and gastroesophageal junction carcinoma. Nevertheless, details on therapeutic approaches in addition to surgery...

    Authors: Daniel Buergy, Frank Lohr, Tobias Baack, Kerstin Siebenlist, Stefan Haneder, Henrik Michaely, Frederik Wenz and Judit Boda-Heggemann
    Citation: Radiation Oncology 2012 7:192
  36. Helical Tomotherapy (HT) has unique capacities for the radiotherapy of large and complicated target volumes. Next generation Dynamic Jaw/Dynamic Couch HT delivery promises faster treatments and reduced exposur...

    Authors: Sonja Krause, Sebastian Beck, Kai Schubert, Steffen Lissner, Susanta Hui, Klaus Herfarth, Juergen Debus and Florian Sterzing
    Citation: Radiation Oncology 2012 7:191
  37. Carbon fiber (CF) is now the material of choice for radiation therapy couch tops. Initial designs included side metal bars for rigidity; however, with the advent of IGRT, involving on board imaging, new thicke...

    Authors: Christopher F Njeh, Jason Parker, Joseph Spurgin and Elizabeth Rhoe
    Citation: Radiation Oncology 2012 7:190
  38. Limited data guide radiotherapy choices for patients with brain metastases. This survey aimed to identify patient, physician, and practice setting variables associated with reported preferences for different t...

    Authors: Marie-Adele S Kress, Naren Ramakrishna, Solomon B Makgoeng, Keith R Unger and Arnold L Potosky
    Citation: Radiation Oncology 2012 7:188
  39. Clinical studies have demonstrated that HPV induced tumors constitute a specific subclass of cancer with a better response to radiation treatment. The purpose of this study was to investigate meaning of viral ...

    Authors: Katja Lindel, Stefan Rieken, Sigrid Daffinger, Klaus J Weber, Ethel-Michele de Villiers and Jürgen Debus
    Citation: Radiation Oncology 2012 7:187
  40. Radiotherapy in Hodgkin’s Lymphoma (HL) is currently evolving with new attempts to further reduce radiation volumes to the involved-node concept (Involved Nodes Radiation Therapy, INRT) and with the use of int...

    Authors: Christian Fiandra, Andrea Riccardo Filippi, Paola Catuzzo, Angela Botticella, Patrizia Ciammella, Pierfrancesco Franco, Valeria Casanova Borca, Riccardo Ragona, Santi Tofani and Umberto Ricardi
    Citation: Radiation Oncology 2012 7:186
  41. Histone deacetylase (HDAC) plays an important role in the deacetylation of histone, which can alter gene expression patterns and affect cell behavior associated with malignant transformation. The aims of this ...

    Authors: Yang Han, Yong Zhang, Lian-he Yang, Xiao-yi Mi, Shun-dong Dai, Qing-chang Li, Hong-tao Xu, Juan-han Yu, Guang Li, Jing Zhao, Chong Han, Xi-ming Yuan and En-hua Wang
    Citation: Radiation Oncology 2012 7:183

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions